Efficacy of Dual Glucagon and Glucagon-like Peptide-1 Receptor Agonists Across the Cardiometabolic Continuum: A Review of Current Clinical Evidence

Efficacy of Dual Glucagon and Glucagon-like Peptide-1 Receptor Agonists Across the Cardiometabolic Continuum: A Review of Current Clinical Evidence

The global surge in cardiometabolic diseases, including type 2 diabetes, obesity, and cardiovascular diseases, has reached pandemic levels, demanding bold and innovative solutions. Dual glucagon (Gcg) and glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking advancement in the...

Full description

Saved in:
Bibliographic Details
Main Authors: Panagiotis Stachteas, Athina Nasoufidou, Paschalis Karakasis, Markella Koiliari, Efstratios Karagiannidis, Theocharis Koufakis, Nikolaos Fragakis, Dimitrios Patoulias
Format: Article
Language:English
Published: IMR Press 2025-07-01
Series:Reviews in Cardiovascular Medicine
Subjects:
dual agonists
glp-1 receptor agonists
glucagon receptor
cardiometabolic diseases
obesity
type 2 diabetes
metabolic dysfunction-associated steatotic liver disease (masld)
Online Access:https://www.imrpress.com/journal/RCM/26/7/10.31083/RCM39691
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.imrpress.com/journal/RCM/26/7/10.31083/RCM39691

Similar Items